BioCardia (BCDA) Gross Profit Growth (1y) (2012 - 2021)
Powered by 
Analysis
BioCardia (BCDA) Gross Profit Growth (1y) (2012 - 2021) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 26.90% |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 403.28% |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 56.99% |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | -45.07% |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 21.00% |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 71.74% |
| Sep 30, 2021 | 2,314.71% |
| Jun 30, 2021 | 155.56% |
| Dec 31, 2020 | -74.16% |
| Sep 30, 2020 | -80.00% |
| Jun 30, 2020 | 125.71% |
| Mar 31, 2020 | -69.09% |
| Dec 31, 2019 | 1,469.23% |
| Sep 30, 2019 | 780.00% |
| Jun 30, 2019 | -200.96% |
| Mar 31, 2019 | 161.90% |
| Dec 31, 2018 | 80.00% |
| Sep 30, 2018 | -47.06% |
| Jun 30, 2018 | 214.29% |
| Mar 31, 2018 | 210.53% |
| Dec 31, 2017 | -109.68% |
| Sep 30, 2017 | 78.48% |
| Jun 30, 2017 | -658.33% |
| Mar 31, 2017 | 20.83% |
| Jun 30, 2013 | 305.88% |